EcoSynthetix to Host 2026 Third Quarter Results Conference Call
EcoSynthetix Inc. has announced it will release its 2026 third-quarter financial results and host a conference call on November 4, 2026.
Stocks · News reference
Helen Of Troy Posts Upbeat Q2 Earnings, Joins Pacira Biosciences, Wolfspeed And Other Big Stocks Moving Higher On Thursday
U.S. stocks fell, while Helen of Troy jumped 15.5% on strong earnings and raised guidance. Pacira soared 44.1% on Viatris acquisition news.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
First Tracks Biotherapeutics, C3.ai, CCC Intelligent Solutions And Other Big Stocks Moving Higher On Monday
U.S. stocks mixed; First Tracks Biotherapeutics surged 18% on positive celiac trial results, while C3.ai, Liquidia and others also gained.
Reported Earlier, 'Oil Tanker Rates Surge Amid Rising Attacks, Longer Voyages' - WSJ
https://www.wsj.com/finance/commodities-futures/oil-falls-on-hopes-that-russian-diesel-can-ease-global-fuel-shortages-db1651af
Tanker Rates Hit $1.3M a Day As 9 Shipping Stocks Double in 2026
Nine of 13 U.S.-listed tanker stocks have more than doubled this year. For comparison, the SPDR S&P 500 ETF Trust is up 13.5%.
All You Need to Know About Haemonetics (HAE) Rating Upgrade to Buy
Haemonetics (HAE) has been upgraded to a Zacks Rank #2 (Buy) rating, reflecting upward trends in earnings estimates over the past three months. The company, which provides blood management systems, is positioned in the top 20% of Zacks-covered stocks based on estimate revisions, suggesting potential near-term stock price appreciation.
Haemonetics Receives FDA Approval For PerQseal Elite Vascular Closure System For Large-Bore Arterial Procedures
Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced U.S. Food and Drug Administration (FDA) approval